Market Rumors: GlaxoSmithKline, Keppel, Jasmine Broadband

By Chelsea Naso (November 25, 2014, 5:47 PM EST) -- GlaxoSmithKline PLC, the U.K.'s biggest drugmarker, is looking to sell its first euro bonds since 2009 and is currently marketing €2.5 billion ($3.1 billion) of notes maturing in five and 10 years, Bloomberg reported Tuesday citing people familiar with the matter. The push comes as borrowing costs in the currency approach historic lows, with average yields for investment-grade bonds in euros down to 1.18 percent — two basis points from a record low reached earlier this month, the report said....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!